Gastrointestinal Disorders
Research activity includes irritable bowel syndrome, with a focus on global symptom burden and patient-reported digestive outcomes, alongside interest in gut microbiota modulation during antibiotic therapy.
- Non-constipated irritable bowel syndrome
- Saccharomyces boulardii CNCM I-745
- Microbiome support during antibiotic exposure
The sponsor’s work in this area centers on digestive symptom management and the interaction between antimicrobial treatment and intestinal microbial balance.
Rare Metabolic Disease
Clinical research covers primary hyperoxaluria across multiple subtypes, with attention to reducing urinary oxalate excretion and addressing the metabolic consequences of inherited oxalate overproduction.
- Primary hyperoxaluria type 1
- Primary hyperoxaluria type 2
- Primary hyperoxaluria type 3
Interest in this field reflects involvement in disorders linked to kidney stone formation and systemic metabolic complications.
Neurology and Epilepsy
Biocodex supports studies in Dravet syndrome, a severe developmental and epileptic encephalopathy, with therapeutic interest in seizure control and neurological disease management.
- Dravet syndrome
- Epileptic encephalopathy
- Pediatric neurological disorders
This area highlights engagement with complex childhood-onset neurological conditions requiring long-term clinical care.
Renal Impairment and Pharmacokinetics
Research also addresses renal impairment, with interest in how kidney dysfunction affects drug handling and treatment exposure in patients receiving oral therapies.
- Renal function impairment
- Pharmacokinetic evaluation
- Oral medicinal product performance
These studies connect kidney disease with medication use in populations requiring careful therapeutic adaptation.
